Organism name | Corbicula japonica |
---|---|
Genus | Corbicula |
Family | Corbiculidae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Corbicula japonica |
---|---|
Linked NCBI taxonomy ID | 141464 |
Linked level | species |
Family in NCBI taxonomy | Corbiculidae |
---|---|
ID | 45947 |
Kingdom (Superkingdom) in NCBI taxonomy | Metazoa |
---|---|
ID | 33208 |
Plant class | |
---|---|
ID |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00000919
![]() |
beta-Carotene
|
CHEMBL1293
CHEMBL1966639 |
D019207
|
7 / 12 / 11 | 104 / 19 | No. 26 | No. 59 |
![]() |
C00000922
![]() |
Canthaxanthin
/ beta-Carotene-4,4'-dione |
CHEMBL1329004
|
D016644
|
4 / 4 / 3 | 0 / 1 | No. 26 | No. 59 |
![]() |
C00000925
![]() |
Myxoxanthine
/ beta-Echinenone |
C105515
|
No. 26 | No. 59 |
![]() |
|||
C00000931
![]() |
Zeaxanthin
/ all-trans-Zeaxanthin |
CHEMBL1357855
CHEMBL2359248 |
C005881
|
4 / 2 / 3 | 1 / 0 | No. 26 | No. 59 |
![]() |
C00003765
![]() |
alpha-Carotene
|
No. 26 | No. 59 |
![]() |
||||
C00023232
![]() |
7,8-Didehydro-beta,beta-caroten-3-ol
|
No. 26 | No. 59 |
![]() |
||||
C00003776
![]() |
Lutein
/ (all-E)-Lutein / all-trans-(+)-Xanthophyll / (3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol |
CHEMBL173929
CHEMBL172477 CHEMBL1559643 CHEMBL1979448 |
D014975
|
4 / 2 / 3 | 7 / 2 | No. 26 | No. 59 |
![]() |
C00022834
![]() |
Deoxylutein II
/ Anhydrolutein I |
CHEMBL172328
|
No. 26 | No. 59 |
![]() |
|||
C00022836
![]() |
(3R,6'R)-7,8-Didehydro-beta,epsilon-caroten-3-ol
|
No. 26 | No. 59 |
![]() |
||||
C00022862
![]() |
Alloxanthin
/ Cynthiaxanthin / Pectenoxanthin / (3R,3'R)-7,7',8,8'-Tetradehydro-beta,beta-carotene-3,3'-diol |
C006462
|
No. 26 | No. 59 |
![]() |
|||
C00022863
![]() |
Diatoxanthin
/ (3R,3'R)-7,8-Didehydro-beta,beta-carotene-3,3'-diol |
C103105
|
No. 26 | No. 59 |
![]() |
|||
C00022909
![]() |
Pectenol A
/ (3S,3'R,4R)-7',8'-Didehydro-beta,beta-carotene-3,3',4-triol |
No. 26 | No. 59 |
![]() |
||||
C00022916
![]() |
Loroxanthin
/ (3R,3'R,6'R)-beta,epsilon-Carotene-3,3',19-triol |
No. 26 | No. 59 |
![]() |
||||
C00023231
![]() |
Isocryptoxanthin
/ beta,beta-Caroten-4-ol |
No. 26 | No. 59 |
![]() |
||||
C00023230
![]() |
(6'R)-alpha-Echinenone
|
No. 26 | No. 59 |
![]() |
||||
C00023234
![]() |
(3S,3'S,4R,4'R)-Crustaxanthin
|
No. 26 | No. 59 |
![]() |
||||
C00023033
![]() |
Halocynthiaxanthin
/ (3S,3'R,5R,6S)-7',8'-Didehydro-5,6-epoxy-5,6,7,8-tetrahydro-8-oxo-beta,beta-carotene-3,3'-diol |
CHEMBL450953
|
C073045
|
No. 114 | No. 59 |
![]() |
||
C00023240
![]() |
Fucoxanthinol
|
C483031
|
No. 114 | No. 59 |
![]() |
|||
C00003773
![]() |
Fucoxanthin
|
CHEMBL1575074
|
C025164
|
12 / 17 / 46 | 6 / 3 | No. 114 | No. 59 |
![]() |
C00023238
![]() |
Diatoxanthin 3,6-epoxide
|
No. 114 | No. 59 |
![]() |
||||
C00022925
![]() |
Heteroxanthin
/ (3S,3'R,5R,6R)-7',8'-Didehydro-5,6-dihydro-3,3',5,6-tetrahydroxy-beta,beta-carotene |
No. 114 | No. 59 |
![]() |
||||
C00023237
![]() |
6-Epiheteroxanthin
|
No. 114 | No. 59 |
![]() |
||||
C00022955
![]() |
Cycloviolaxanthin
/ (3S,3'S,5R,5'R,6R,6'R)-3,6:3',6'-Diepoxy-5,5',6,6'-tetrahydro-5,5'-dihydroxy-beta,beta-carotene |
No. 114 | No. 59 |
![]() |
||||
C00023166
![]() |
Crassostreaxanthin A
|
No. 262 | No. 59 |
![]() |
||||
C00023236
![]() |
Corbiculaxanthin 3'-acetate
|
No. 664 | No. 59 |
![]() |
||||
C00023235
![]() |
Corbiculaxanthin
|
No. 664 | No. 59 |
![]() |
||||
C00023239
![]() |
Diadinochrome
|
No. 664 | No. 59 |
![]() |
||||
C00023233
![]() |
7',8'-Didehydrodeepoxyneoxanthin
|
No. 664 | No. 59 |
![]() |
||||
C00022950
![]() |
Mutatoxanthin
/ (3S,3'R,5R)-5,8-Epoxy-5,8-dihydro-beta,beta-carotene-3,3'-diol |
No. 664 | No. 59 |
![]() |
||||
C00023163
![]() |
Peridininol
|
No. 782 |
![]() |
|||||
C00023246
![]() |
Pyrrhoxanthinol 5,8-furanoxide
|
No. 782 |
![]() |
|||||
C00023244
![]() |
Peridininol 5,8-furanoxide
|
No. 782 |
![]() |
|||||
C00023245
![]() |
Pyrrhoxanthin 5,8-furanoxide
|
No. 782 |
![]() |
|||||
C00023162
![]() |
Pyrrhoxanthin
|
No. 782 |
![]() |
|||||
C00023161
![]() |
Pyrrhoxanthinol
|
No. 782 |
![]() |
|||||
C00023241
![]() |
Peridinin
/ Sulcatoxanthin |
CHEMBL1980535
|
C016040
|
No. 782 |
![]() |
|||
C00023242
![]() |
Peridinin 5,8-furanoxide
|
No. 782 |
![]() |
|||||
C00023243
![]() |
Hydratoperidinin
|
No. 782 |
![]() |
|||||
C00023247
![]() |
Cyclopyrrhoxanthin
|
No. 782 |
![]() |
|||||
C00023173
![]() |
beta-Carotenone
|
No. 2278 |
![]() |
|||||
C00023169
![]() |
Semi-alpha-carotenone
|
No. 2278 |
![]() |
|||||
C00023168
![]() |
Semi-beta-carotenone
|
No. 2278 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
O75496 | Geminin | Unclassified protein | C00000919 C00000931 C00003773 C00003776 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000922 C00000931 C00003776 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000931 C00003773 C00003776 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00000931 C00003773 C00003776 | 2 / 3 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000919 C00003773 | 0 / 1 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00000922 C00003773 | 4 / 3 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00000919 C00000922 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00003773 | 7 / 37 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000919 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00003773 | 2 / 0 |
P06280 | Alpha-galactosidase A | Enzyme | C00003773 | 1 / 1 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00000922 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00000919 | 11 / 10 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00003773 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00003773 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00003773 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00003773 | 1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000919 | 1 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000919 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00003773
C00003776
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00000919
C00003776
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000919
C00003773
|
4255 | MGMT | O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63) |
C00000919
|
2697 | GJA1, AVSD3, CMDR, CX43, DFNB38, GJAL, HLHS1, HSS, ODDD | gap junction protein, alpha 1, 43kDa |
C00003773
|
2705 | GJB1, CMTX, CMTX1, CX32 | gap junction protein, beta 1, 32kDa |
C00003773
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00003773
|
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00000931
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00003776
|
847 | CAT | catalase (EC:1.11.1.6) |
C00003776
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00003776
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00003776
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00003776
|
124 | ADH1A, ADH1 | alcohol dehydrogenase 1A (class I), alpha polypeptide (EC:1.1.1.1) |
C00000919
|
128 | ADH5, ADH-3, ADHX, FALDH, FDH, GSH-FDH, GSNOR | alcohol dehydrogenase 5 (class III), chi polypeptide (EC:1.1.1.1 1.1.1.284) |
C00000919
|
221 | ALDH3B1, ALDH4, ALDH7 | aldehyde dehydrogenase 3 family, member B1 (EC:1.2.1.5) |
C00000919
|
8659 | ALDH4A1, ALDH4, P5CD, P5CDh | aldehyde dehydrogenase 4 family, member A1 (EC:1.2.1.88) |
C00000919
|
287 | ANK2, ANK-2, LQT4, brank-2 | ankyrin 2, neuronal |
C00000919
|
288 | ANK3, ANKYRIN-G, MRT37 | ankyrin 3, node of Ranvier (ankyrin G) |
C00000919
|
427 | ASAH1, AC, ACDase, ASAH, PHP, PHP32, SMAPME | N-acylsphingosine amidohydrolase (acid ceramidase) 1 (EC:3.5.1.23) |
C00000919
|
51665 | ASB1, ASB-1 | ankyrin repeat and SOCS box containing 1 |
C00000919
|
140462 | ASB9 | ankyrin repeat and SOCS box containing 9 |
C00000919
|
9531 | BAG3, BAG-3, BIS, CAIR-1, MFM6 | BCL2-associated athanogene 3 |
C00000919
|
9530 | BAG4, BAG-4, SODD | BCL2-associated athanogene 4 |
C00000919
|
9529 | BAG5, BAG-5 | BCL2-associated athanogene 5 |
C00000919
|
53630 | BCMO1, BCDO, BCDO1, BCMO, BCO, BCO1 | beta-carotene 15,15'-monooxygenase 1 (EC:1.14.99.36) |
C00000919
|
999 | CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO | cadherin 1, type 1, E-cadherin (epithelial) |
C00000919
|
8837 | CFLAR, CASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1, FLAME1, FLIP, I-FLICE, MRIT, c-FLIP, c-FLIPL, c-FLIPR, c-FLIPS | CASP8 and FADD-like apoptosis regulator |
C00000919
|
9071 | CLDN10, CPETRL3, OSP-L | claudin 10 |
C00000919
|
51208 | CLDN18, SFTA5, SFTPJ | claudin 18 |
C00000919
|
1277 | COL1A1, OI4 | collagen, type I, alpha 1 |
C00000919
|
1282 | COL4A1, HANAC, ICH, POREN1, arresten | collagen, type IV, alpha 1 |
C00000919
|
1284 | COL4A2, ICH, POREN2 | collagen, type IV, alpha 2 |
C00000919
|
8738 | CRADD, MRT34, RAIDD | CASP2 and RIPK1 domain containing adaptor with death domain |
C00000919
|
1508 | CTSB, APPS, CPSB | cathepsin B (EC:3.4.22.1) |
C00000919
|
6387 | CXCL12, IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1, SDF1A, SDF1B | chemokine (C-X-C motif) ligand 12 |
C00000919
|
6372 | CXCL6, CKA-3, GCP-2, GCP2, SCYB6 | chemokine (C-X-C motif) ligand 6 |
C00000919
|
4283 | CXCL9, CMK, Humig, MIG, SCYB9, crg-10 | chemokine (C-X-C motif) ligand 9 |
C00000919
|
7852 | CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM | chemokine (C-X-C motif) receptor 4 |
C00000919
|
1592 | CYP26A1, CP26, CYP26, P450RAI, P450RAI1 | cytochrome P450, family 26, subfamily A, polypeptide 1 (EC:1.14.-.-) |
C00000919
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00000919
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00000919
|
64816 | CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 (EC:1.14.14.1) |
C00000919
|
1746 | DLX2, TES-1, TES1 | distal-less homeobox 2 |
C00000919
|
1748 | DLX4, BP1, DLX7, DLX8, DLX9 | distal-less homeobox 4 |
C00000919
|
2068 | ERCC2, COFS2, EM9, TTD, XPD | excision repair cross-complementing rodent repair deficiency, complementation group 2 (EC:3.6.4.12) |
C00000919
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00000919
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00000919
|
23017 | FAIM2, LFG, LFG2, NGP35, NMP35, TMBIM2 | Fas apoptotic inhibitory molecule 2 |
C00000919
|
355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00000919
|
3169 | FOXA1, HNF3A, TCF3A | forkhead box A1 |
C00000919
|
2627 | GATA6 | GATA binding protein 6 |
C00000919
|
2633 | GBP1 | guanylate binding protein 1, interferon-inducible |
C00000919
|
81025 | GJA9, CX58, CX59, GJA10 | gap junction protein, alpha 9, 59kDa |
C00000919
|
373156 | GSTK1, GST, GST_13-13, GST13, GST13-13, GSTK1-1, hGSTK1 | glutathione S-transferase kappa 1 (EC:2.5.1.18) |
C00000919
|
2946 | GSTM2, GST4, GSTM, GSTM2-2, GTHMUS | glutathione S-transferase mu 2 (muscle) (EC:2.5.1.18) |
C00000919
|
2948 | GSTM4, GSTM4-4, GTM4 | glutathione S-transferase mu 4 (EC:2.5.1.18) |
C00000919
|
2949 | GSTM5, GSTM5-5, GTM5 | glutathione S-transferase mu 5 (EC:2.5.1.18) |
C00000919
|
2954 | GSTZ1, GSTZ1-1, MAAI, MAI | glutathione S-transferase zeta 1 (EC:2.5.1.18 5.2.1.2) |
C00000919
|
3204 | HOXA7, ANTP, HOX1, HOX1.1, HOX1A | homeobox A7 |
C00000919
|
3216 | HOXB6, HOX2, HOX2B, HU-2, Hox-2.2 | homeobox B6 |
C00000919
|
3226 | HOXC10, HOX3I | homeobox C10 |
C00000919
|
3448 | IFNA14, IFN-alphaH, LEIF2H | interferon, alpha 14 |
C00000919
|
3449 | IFNA16, IFN-alphaO | interferon, alpha 16 |
C00000919
|
3451 | IFNA17, IFN-alphaI, IFNA, INFA, LEIF2C1 | interferon, alpha 17 |
C00000919
|
3442 | IFNA5, IFN-alpha-5, IFN-alphaG, INA5, INFA5, leIF_G | interferon, alpha 5 |
C00000919
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00000919
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00000919
|
3394 | IRF8, H-ICSBP, ICSBP, ICSBP1, IRF-8 | interferon regulatory factor 8 |
C00000919
|
50805 | IRX4, IRXA3 | iroquois homeobox 4 |
C00000919
|
3688 | ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
C00000919
|
3691 | ITGB4, CD104 | integrin, beta 4 |
C00000919
|
3713 | IVL | involucrin |
C00000919
|
3875 | KRT18, CYK18, K18 | keratin 18 |
C00000919
|
3880 | KRT19, CK19, K19, K1CS | keratin 19 |
C00000919
|
3849 | KRT2, CK-2e, K2e, KRT2A, KRT2E, KRTE | keratin 2 |
C00000919
|
3855 | KRT7, CK7, K2C7, K7, SCL | keratin 7 |
C00000919
|
3856 | KRT8, CARD2, CK-8, CK8, CYK8, K2C8, K8, KO | keratin 8 |
C00000919
|
8022 | LHX3, CPHD3, LIM3, M2-LHX3 | LIM homeobox 3 |
C00000919
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00000919
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00000919
|
4153 | MBL2, COLEC1, HSMBPC, MBL, MBL2D, MBP, MBP-C, MBP1, MBPD | mannose-binding lectin (protein C) 2, soluble |
C00000919
|
4170 | MCL1, BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT | myeloid cell leukemia sequence 1 (BCL2-related) |
C00000919
|
4212 | MEIS2, HsT18361, MRG1 | Meis homeobox 2 |
C00000919
|
4222 | MEOX1, KFS2, MOX1 | mesenchyme homeobox 1 |
C00000919
|
840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00003773
|
3110 | MNX1, HB9, HLXB9, HOXHB9, SCRA1 | motor neuron and pancreas homeobox 1 |
C00000919
|
4439 | MSH5, G7, MUTSH5, NG23 | mutS homolog 5 |
C00000919
|
4586 | MUC5AC, MUC5, TBM, leB | mucin 5AC, oligomeric mucus/gel-forming |
C00000919
|
4842 | NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS | nitric oxide synthase 1 (neuronal) (EC:1.14.13.39) |
C00000919
|
8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00000919
|
4973 | OLR1, CLEC8A, LOX1, LOXIN, SCARE1, SLOX1 | oxidized low density lipoprotein (lectin-like) receptor 1 |
C00000919
|
5098 | PCDHGC3, PC43, PCDH-GAMMA-C3, PCDH2 | protocadherin gamma subfamily C, 3 |
C00000919
|
5359 | PLSCR1, MMTRA1B | phospholipid scramblase 1 |
C00000919
|
57048 | PLSCR3 | phospholipid scramblase 3 |
C00000919
|
57088 | PLSCR4, TRA1 | phospholipid scramblase 4 |
C00000919
|
10635 | RAD51AP1, PIR51 | RAD51 associated protein 1 |
C00000919
|
5892 | RAD51D, BROVCA4, R51H3, RAD51L3, TRAD | RAD51 paralog D |
C00000919
|
5914 | RARA, NR1B1, RAR | retinoic acid receptor, alpha |
C00000919
|
5915 | RARB, HAP, NR1B2, RRB2 | retinoic acid receptor, beta |
C00000919
|
5918 | RARRES1, LXNL, TIG1 | retinoic acid receptor responder (tazarotene induced) 1 |
C00000919
|
5950 | RBP4, RDCCAS | retinol binding protein 4, plasma |
C00000919
|
6256 | RXRA, NR2B1 | retinoid X receptor, alpha |
C00000919
|
949 | SCARB1, CD36L1, CLA-1, CLA1, HDLQTL6, SR-BI, SRB1 | scavenger receptor class B, member 1 |
C00000919
|
4990 | SIX6, MCOPCT2, OPTX2, Six9 | SIX homeobox 6 |
C00000919
|
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00000919
|
9517 | SPTLC2, HSN1C, LCB2, LCB2A, NSAN1C, SPT2, hLCB2a | serine palmitoyltransferase, long chain base subunit 2 (EC:2.3.1.50) |
C00000919
|
6720 | SREBF1, SREBP-1c, SREBP1, bHLHd1 | sterol regulatory element binding transcription factor 1 |
C00000919
|
7052 | TGM2, G-ALPHA-h, GNAH, TG2, TGC | transglutaminase 2 (EC:2.3.2.13) |
C00000919
|
7047 | TGM4, TGP, hTGP | transglutaminase 4 (EC:2.3.2.13) |
C00000919
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000919
|
3604 | TNFRSF9, 4-1BB, CD137, CDw137, ILA | tumor necrosis factor receptor superfamily, member 9 |
C00000919
|
8743 | TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL | tumor necrosis factor (ligand) superfamily, member 10 |
C00000919
|
10190 | TXNDC9, APACD, PHLP3 | thioredoxin domain containing 9 |
C00000919
|
7517 | XRCC3, CMM6 | X-ray repair complementing defective repair in Chinese hamster cells 3 |
C00000919
|
OMIM | preferred title | UniProt |
---|---|---|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P84022
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#211980 | Lung cancer |
P04637
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
KEGG | name | UniProt |
---|---|---|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
|
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00033 | Adrenal carcinoma |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
|
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00125 | Fabry disease |
P06280
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D056486 | Drug-Induced Liver Injury |
C00003773
C00000919 |
D003930 | Diabetic Retinopathy |
C00000919
|
D015430 | Weight Gain |
C00003773
|
D007939 | Leukemia L1210 |
C00003776
|
D014605 | Uveitis |
C00003776
|
D005128 | Eye Diseases |
C00000922
|
D000435 | Alcoholic Intoxication |
C00000919
|
D001145 | Arrhythmias, Cardiac |
C00000919
|
D053627 | Asthenozoospermia |
C00000919
|
D002545 | Brain Ischemia |
C00000919
|
D006528 | Carcinoma, Hepatocellular |
C00000919
|
D002318 | Cardiovascular Diseases |
C00000919
|
D006949 | Hyperlipidemias |
C00003773
|
D006526 | Hepatitis C |
C00000919
|
D015658 | HIV Infections |
C00000919
|
D006986 | Hypervitaminosis A |
C00000919
|
D008107 | Liver Diseases |
C00000919
|
D008113 | Liver Neoplasms |
C00000919
|
D008114 | Liver Neoplasms, Experimental |
C00000919
|
D008175 | Lung Neoplasms |
C00000919
|
D009369 | Neoplasms |
C00000919
|
D009845 | Oligospermia |
C00000919
|
D013272 | Stomach Diseases |
C00000919
|
D013276 | Stomach Ulcer |
C00000919
|